Immunomodulatory activity of a chymotrypsin inhibitor from Momordica cochinchinensis seeds

Journal of Peptide Science

Volumn 12, Issue 9, 2006, Pages 605-611

  Tsoi, Alex Yuen Kam ^a   Ng, Tzi Bun ^a   Fong, Wing Ping ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antiinflammatory; Chymotrypsin inhibitor; Immunomodulatory; Momordica cochinchinensis

Indexed keywords

CHINESE DRUG; CHYMOTRYPSIN INHIBITOR; CONCANAVALIN A; HYDROGEN PEROXIDE; INTERLEUKIN 2; MOMORDICA COCHINCHINENSIS EXTRACT; MUBIEZHI; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG ISOLATION; IMMUNE SYSTEM; IMMUNOMODULATION; LYMPHOCYTE; MACROPHAGE; MOMORDICA; MOMORDICA COCHINCHINENSIS; MOUSE; NEUTROPHIL; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BONE MARROW CELLS; CHYMOTRYPSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOLOGIC FACTORS; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED BALB C; MOMORDICA; PLANT PROTEINS; SEEDS; SERINE PROTEINASE INHIBITORS; SPLEEN;

CUCURBITACEAE; MOMORDICA COCHINCHINENSIS;

EID: 33748753164     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.765     Document Type: Article

References (30)

1. Ossevoort MA, Ringers J, Boon L, Lorre K, van den Hout Y, Kuhn EM, de Boer M, Jonker M, de Waele P. Blocking of costimulation prevents kidney graft rejection in rhesus monkeys. Transplant. Proc. 1998; 30: 2165-2166.
2. Schorlemmer HU, Bartlett RR, Kurrle R. Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model. Transplant. Proc. 1999; 31: 851-853.
3. Tchorzewski H, Fornalczyk E, Pasnik J. Protease inhibitors diminish lymphocyte stimulation in vitro. Immunol. Lett. 1995; 46: 237-240.
4. Wright CD, Kennedy JA, Zitnik RJ, Kashem MA. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor. Biochem. Biophys. Res. Commun. 1999; 254: 614-617.
5. Jin FY, Nathan C, Radzioch D, Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997; 88: 417-426.
6. Sano C, Shimizu T, Tomioka H. Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages. Cytokine 2003; 21: 38-42.
7. Vilic IM, Prokic LM, Spuzic IV. Modulation of guinea pig peritoneal macrophage migration in vitro: effects of protease inhibitors. Immunol. Lett. 1987; 4: 271-276.
8. Cheung SC, Li NH. Chinese Medicinal Herbs of Hong Kong. Vol. 4. Commercial Press: Hong Kong, 1985; 146.
9. Tsoi AYK, Wong RCH, Ng TB, Fong WP. First report on a potato I family chymotrypsin inhibitor from the seeds of a Cucurbitaceous plant, Momordica cochinchinensis. Biol. Chem. 2004; 385: 185-189.
10. Tsoi AYK, Wong RCH, Ng TB, Fong WP. Antioxidative effect of a chymotrypsin inhibitor from Momordica cochinchinensis (Cucurbitaceae) seeds in a primary rat hepatocyte culture. J. Pept. Sci. 2005; 11: 665-668.
11. Chu KT, Ng TB. Smilaxin, a novel protein with immunostimulatory, anti-proliferative, and HIV-1-reverse transcriptase inhibitory activities from fresh Smilax glabra rhizomes. Biochem. Biophys. Res. Commun. 2006; 340: 118-124.
12. Gramatzki M, Strong DM, Grove SB, Bonnard GD. Cryopreserved human cultured T cells as responder cells for the quantitative measurement of interleukin-2: improvement of the assay. J. Immunol. Methods 1982; 53: 209-220.
13. Zhao KS, Mancini C, Doria G. Enhancement of the immune response in mice by Astragalus membranaceus extracts. Immunopharmacology 1990; 20: 225-233.
14. Hu S, Concha C, Lin F, Persson Waller K. Adjuvant effect of ginseng extracts on the immune responses to immunisation against Staphylococcus aureus in dairy cattle. Vet. Immunol. Immunopathol. 2003; 91: 29-37.
15. Huang B, Ng TB, Fong WP, Wan CC, Yeung HW. Isolation of a trypsin inhibitor with deletion of N-terminal pentapeptide from the seeds of Momordica cochinchinensis, the Chinese drug mubiezhi. Int. J. Biochem. Cell Biol. 1999; 31: 707-715.
16. Hernandez JF, Gagnon J, Chiche L, Nguyen TM, Andrieu JP, Heitz A, Trinh Hong T, Pham TT, Le Nguyen D. Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure. Biochemistry 2000; 39: 5722-5730.
17. Wong RCH, Fong WP, Ng TB. Multiple trypsin inhibitors from Momordica cochinchinensis seeds, the Chinese drug mubiezhi. Peptides 2004; 25: 163-169.
18. Nagai K, Nakamura T, Koyama J. Characterization of macrophage proteases involved in the ingestion of antigen-antibody complexes by the use of protease inhibitors. FEBS Lett. 1978; 92: 299-302.
19. Flannelly J, Chambers MG, Dudhia J, Hembry RM, Murphy G, Mason RM, Bayliss MT. Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthr. Cartil. 2002; 10: 722-733.
20. Ye XY, Ng TB, Rao PF. A Bowman-Birk-type trypsin-chymotrypsin inhibitor from broad beans. Biochem. Biophys. Res. Commun. 2001; 289: 91-96.
21. Shibata H, Yamamoto I. Induction of prolonged elevation of interleukin 2 in the culture medium of murine splenocytes by their precultivation before mitogenic stimulations and its potentiation by glucocorticoid treatment and restraint stress loading. Jpn. J. Pharmacol. 1990; 52: 523-532.
22. Mazzone A, de Servi S, Vezzoli M, Fossati G, Mazzucchelli I, Gritti D, Ottini E, Mussini A, Specchia G. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 1999; 145: 369-374.
23. Nikawa T, Ikemoto M, Watanabe C, Kitano T, Kano M, Yoshimoto M, Towatari T, Katunuma N, Shizuka F, Kishi K. A cysteine protease inhibitor prevents suspension-induced declines in bone weight and strength in rats. J. Physiol. Anthropol. Appl. Human Sci. 2002; 21: 51-57.
24. Belleau B, Lajoie G, Sauve G, Rao VS, di Paola A. Some remarkable effects of thiopeptide and derived linkages on lysozyme release from neutrophils by esters of the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (f-Met-Leu-Phe-OR). Int. J. Immunopharmacol. 1989; 11: 467-471.
25. Kitagawa S, Takaku F, Sakamoto S. Serine protease inhibitors inhibit superoxide production by human polymorphonuclear leukocytes and monocytes stimulated by various surface active agents. FEBS Lett. 1979; 107: 331-334.
26. Abate A, Schroder H. Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity: possible role for NF-kappaB. Life Sci. 2001; 62: 1081-1088.
27. Zhu J, Nathan C, Ding A. Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor. Biochim. Biophys. Acta 1999; 1451: 219-223.
28. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 1992; 10: 153-187.
29. Huitinga I, Ruuls SR, Jung S, van Rooijen N, Hartung HP, Dijkstra CD. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin. Exp. Immunol. 1995; 100: 344-351.
30. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJ, Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 2499-2504.